GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WPD Pharmaceuticals Inc (XCNQ:WBIO) » Definitions » Accounts Payable & Accrued Expense

WPD Pharmaceuticals (XCNQ:WBIO) Accounts Payable & Accrued Expense : C$0.52 Mil (As of Sep. 2024)


View and export this data going back to 2008. Start your Free Trial

What is WPD Pharmaceuticals Accounts Payable & Accrued Expense?

WPD Pharmaceuticals's quarterly accounts payable & accrued expense declined from Mar. 2024 (C$0.67 Mil) to Jun. 2024 (C$0.61 Mil) and declined from Jun. 2024 (C$0.61 Mil) to Sep. 2024 (C$0.52 Mil).

WPD Pharmaceuticals's annual accounts payable & accrued expense declined from Dec. 2020 (C$0.83 Mil) to Dec. 2022 (C$0.56 Mil) but then increased from Dec. 2022 (C$0.56 Mil) to Dec. 2023 (C$0.60 Mil).

WPD Pharmaceuticals Accounts Payable & Accrued Expense Historical Data

The historical data trend for WPD Pharmaceuticals's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WPD Pharmaceuticals Accounts Payable & Accrued Expense Chart

WPD Pharmaceuticals Annual Data
Trend Jan13 Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Dec20 Dec22 Dec23
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.19 0.83 0.56 0.60

WPD Pharmaceuticals Quarterly Data
Jul19 Oct19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.60 0.60 0.67 0.61 0.52

WPD Pharmaceuticals Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

WPD Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WPD Pharmaceuticals Inc (XCNQ:WBIO) » Definitions » Accounts Payable & Accrued Expense
Comparable Companies
VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX SMMT RPRX OCSE:GMAB XKRX:196170 INCY HKSE:02269 INSM HKSE:01801 SHSE:603392 EXEL
Traded in Other Exchanges
8SV:Germany
Address
700-595 Burrard Street, Suite 401, Vancouver, BC, CAN, V7X 1S8
Website
https://www.wpdpharmaceuticals.com
WPD Pharmaceuticals Inc is a biotechnology research and development company. It focuses on oncology, virology, research, and development of medicinal products involving biological compounds and small molecules.
Executives
Constantine Carmichel Director

WPD Pharmaceuticals Headlines

No Headlines